Split History
ETFs Holding WINT »    WINT Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Windtree Therapeutics is a biopharmaceutical company focused on the development of therapeutics. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. Co.'s heart failure cardiovascular portfolio also includes sarco endoplasmic reticulum Ca2+ -ATPase 2a (SERCA2a) activators. This research program is evaluating these preclinical product candidates, including oral and intravenous SERCA2a activator heart failure compounds. In addition, Co.'s cardiovascular drug product candidates include rostafuroxin, a product candidate for the treatment of hypertension in patients with a specific genetic profile. According to our WINT split history records, Windtree Therapeutics has had 1 split.
WINT split history picture
Windtree Therapeutics (WINT) has 1 split in our WINT split history database. The split for WINT took place on February 24, 2023. This was a 1 for 50 reverse split, meaning for each 50 shares of WINT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 20 share position following the split.

When a company such as Windtree Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the WINT split history from start to finish, an original position size of 1000 shares would have turned into 20 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Windtree Therapeutics shares, starting with a $10,000 purchase of WINT, presented on a split-history-adjusted basis factoring in the complete WINT split history. WINT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $107.50
End price/share: $0.37
Dividends collected/share: $0.00
Total return: -99.66%
Average Annual Total Return: -43.30%
Starting investment: $10,000.00
Ending investment: $34.40
Years: 10.00
Date Ratio
02/24/20231 for 50
WINT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

WOOF Split History
XBIO Split History
XOMA Split History
XRAY Split History
XTNT Split History
ZBH Split History
ZGNX Split History
ZLCS Split History
ZSAN Split History
A Split History

Email EnvelopeFree WINT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
Intrusion Inc. (INTZ)
MicroSectorsTM Travel -3X Inverse Leveraged ETNs due May 29, 2042 (FLYD)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

WINT Insider Buying

WINT Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.